Troponin level at presentation as a prognostic factor among patients presenting with non‐ST‐segment elevation myocardial infarction
Clinical Cardiology · 2024
DOI: 10.1002/clc.24166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology, 2024. Verfasst von Ranel Loutati und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Jesselson Integrated Heart Center, Shaare Zedek Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jer…. Hauptthemen laut MEDLINE: Non-ST Elevated Myocardial Infarction, Percutaneous Coronary Intervention, Myocardial Infarction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Timely reperfusion within 120 min is strongly recommended in patients presenting with non‐ST‐segment myocardial infarction (NSTEMI) with very high‐risk features. Evidence regarding the use of high‐sensitivity cardiac troponin (hs‐cTn) concentration upon admission for the risk‐stratification of patients presenting with NSTEMI to expedite percutaneous coronary intervention (PCI) and thus potentially improve outcomes is limited.
Methods
All patients admitted to a tertiary care center ICCU between July 2019 and July 2022 were included. Hs‐cTnI levels on presentaion were recorded, dividing patients into quartiles based on baseline hs‐cTnI. Association between initial hs‐cTnI and all‐cause mortality during up to 3 years of follow‐up was studied.
Results
A total of 544 NSTEMI patients with a median age of 67 were included. Hs‐cTnI levels in each quartile were: (a) ≤122, (b) 123–680, (c) 681–2877, and (d) ≥2878 ng/L. There was no difference between the initial hs‐cTnI level groups regarding age and comorbidities. A higher mortality rate was observed in the highest hs‐cTnI quartile as compared with the lowest hs‐cTnI quartile (16.2% vs. 7.35%, p = .03) with hazard ratio (HR) for mortality of 2.6 (95% confidence interval [CI]: 1.23–5.4; p = .012) in the unadjusted model, and HR of 2.06 (95% CI: 1.01–4.79; p = .047) with adjustment for age, gender, serum creatinine, and significant comorbidities.
Conclusions
Patients with NSTEMI and higher hs‐cTnI levels upon admission faced elevated mortality risk. This underscores the need for further prospective investigations into early reperfusion strategies' impact on NSTEMI patients' mortality, based on admission troponin elevation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Jesselson Integrated Heart Center, Shaare Zedek Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Department of Cardiology, Barzilai Medical Center, The Ben-Gurion University of the Negev, Beersheba, Israel.
ORCID-Profile: Ranel Loutati
Zitieren
APA
Loutati, R., Perel, N., Bruoha, S., Taha, L., Tabi, M., Marmor, D., Amsalem, I., Hitter, R., Manassra, M., Hamayel, K., Karameh, H., Tommer Maller, Steinmetz, Y., Karmi, M., Shuvy, M., Glikson, M., & Asher, E. (2024). Troponin level at presentation as a prognostic factor among patients presenting with non‐ST‐segment elevation myocardial infarction. Clinical Cardiology. https://doi.org/10.1002/clc.24166
Vancouver
Loutati R, Perel N, Bruoha S, Taha L, Tabi M, Marmor D, et al. Troponin level at presentation as a prognostic factor among patients presenting with non‐ST‐segment elevation myocardial infarction. Clinical Cardiology. 2024. doi:10.1002/clc.24166
BibTeX
@article{Loutati2024,
author = {Loutati, Ranel and Perel, Nimrod and Bruoha, Sharon and Taha, Louay and Tabi, Meir and Marmor, David and Amsalem, Itshak and Hitter, Rafael and Manassra, Mohammed and Hamayel, Kamal and Karameh, Hani and Tommer Maller and Steinmetz, Yoed and Karmi, Mohammad and Shuvy, Mony and Glikson, Michael and Asher, Elad},
title = {Troponin level at presentation as a prognostic factor among patients presenting with non‐ST‐segment elevation myocardial infarction},
journal = {Clinical Cardiology},
year = {2024},
doi = {10.1002/clc.24166}
}
EUVIMED